Aug 21, 2026
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.10 to $0.00.
The split itself did not change the total investment value.
Liminatus Pharma, Inc. Class A Common Stock (LIMN) trades on the NASDAQ Global Select in the Biotechnology industry.
Liminatus Pharma, Inc. Class A Common Stock company overviewThe latest split shown was on August 21, 2026. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
This history records one reverse split, on August 21, 2026.